Division of Veterinary Resources (DVR) Customized Cages
ID: NIH-SS-7012953Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH OLAOBETHESDA, MD, 20892, USA

NAICS

All Other Miscellaneous Manufacturing (339999)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/b5c7d9d7918c40f7b01008c509354ce2/view
Timeline
    Description

    The National Institutes of Health (NIH) is seeking to award a Firm-Fixed-Price purchase order for the procurement of divider panels intended for customized cages used in the Division of Veterinary Resources (DVR). The specific requirement involves opaque vertical cage center dividers for Marmoset QUAD cages, which are essential for animal separation within the NIH's Non-human Primate (NHP) facilities that support ongoing research projects. The NIH has determined that Tecniplast USA is the only known responsible source capable of providing the compatible caging equipment that meets manufacturer standards and warranty requirements. Interested parties that believe they can fulfill this requirement are invited to submit a written capability statement to Ryan Alexander at ryan.alexander@nih.gov by 08:00 a.m. EST on September 11, 2024, as the anticipated award will be issued shortly thereafter.

    Point(s) of Contact
    Ryan Alexander
    ryan.alexander@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Division of Veterinary Resources (DVR) Customized Cages
    Currently viewing
    Special Notice
    Similar Opportunities
    Relocation of Sartorius CompacT SelecT (Annapurna) for decommissioning, and relocation of CompacT SelecT (Quartz) to NCATS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking a qualified vendor to facilitate the relocation and decommissioning of two Sartorius CompacT SelecT systems, specifically the Annapurna and Quartz models, as part of a sole source contract with Sartorius Stedim North America Inc. The project involves two phases: first, disassembling the Annapurna system for storage at the National Center for Advancing Translational Sciences (NCATS), and second, preparing the Quartz system for disassembly, transport, and recommissioning at NCATS. This procurement is critical for ensuring the safe transfer and management of specialized scientific equipment essential for NIH's medical research initiatives. Interested parties must submit their capabilities and proposals by November 6, 2024, to Patricia da Silva at patricia.dasilva@nih.gov, with the contract expected to commence in February 2025.
    Notice of Intent to Sole Source; Monument Medical
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to QuVA Pharma, Inc. for the procurement of compounded intravenous (IV) narcotics for patient care at the NIH Clinical Center. This acquisition aims to secure sterile compounded products that meet the quality standards necessary for ongoing patient treatment, as QuVA Pharma is the sole distributor of these specific IV narcotics in the U.S. market. Interested parties are invited to express their interest and capabilities regarding this procurement, with comments due by November 15, 2024, at 10 AM EST, directed to Kristin Nagashima at kristin.nagashima@nih.gov.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Depuy Synthes Sales Inc. Screws and Plates
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure screws and plates from Depuy Synthes Sales Inc. for use in craniotomy surgeries at the NIH Clinical Center in Bethesda, Maryland. This acquisition aims to replenish essential components of the Fixation Sets currently utilized by the Department of Perioperative Medicine, ensuring that surgeons have the necessary tools for effective skull reconstruction post-surgery. The items requested are critical implants that remain in patients after surgery, and Depuy Synthes Sales Inc. is the exclusive manufacturer of these specific products, which have been in use for over five years. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 7, 2024, at 6:30 AM EST, as this procurement will follow simplified acquisition procedures under FAR Part 13.
    Sources Sought-BioFire Reagents and Test Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is conducting a Sources Sought announcement to identify potential qualified small businesses capable of supplying BioFire Defense reagents and test kits. The NIH's Department of Laboratory Medicine requires these reagents for their BioFire FilmArray analyzers, which are essential for the rapid detection of infectious agents from clinical samples, thereby facilitating timely treatment. Interested vendors must submit their company information, including a capability statement, by 12:00 PM EST on November 7, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the government will not reimburse any costs associated with this request.
    DocuWare License and Annual Maintenance and Software Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm-fixed price contract for DocuWare License and Annual Maintenance and Software Support Services. This procurement aims to provide ongoing support for the DocuWare software system, which is critical for managing over 80,000 active medical and donor records within the Department of Transfusion Medicine, ensuring compliance with federal regulations. The NIH has determined that only DocuWare Corporation can fulfill this requirement without incurring significant costs associated with transitioning to a new vendor, including retraining and system redevelopment. Interested parties may express their interest and capabilities to Tasha Lowe at lowet2@mail.nih.gov by November 4, 2024, at 12 PM.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    In-VitroCell NU-5710 Direct Heat CO2 Incubator
    Active
    Health And Human Services, Department Of
    Combined Synopsis/Solicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking to procure an In-VitroCell NU-5710 Direct Heat CO2 Incubator. This item is typically used for laboratory research and is intended to replace the current incubators being utilized at NIEHS. The procurement is being conducted on a sole source basis with Nuaire, Inc. The delivery date for this purchase is September 30, 2024. Interested parties may submit a capability statement by July 25, 2024, 5:00 PM EST. For more information, please contact Brian Moyer at moyerbd@niehs.nih.gov.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.